Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: J Mol Cell Cardiol. 2010 Oct 28;50(1):107–116. doi: 10.1016/j.yjmcc.2010.10.023

Fig. 2.

Fig. 2

Cardiomyocyte contractile properties in cells from lean and ob/ob obese mice treated with or without TUDCA (50 mg/kg for 5 wks, p.o.). A: Representative cell shortening traces from lean group with or without TUDCA treatment; B: Representative cell shortening traces from obese group with or without TUDCA treatment; C: Resting cell length; D: Peak shortening (PS); E: Maximal velocity of shortening (+dL/dt); F: Maximal velocity of relengthening (−dL/dt); G: Time-to-PS (TPS); and H: Time-to-90% relengthening (TR90). Mean ± SEM, n = 113 – 119 cells from 4 mice per group, * p < 0.05 vs. lean group, # p < 0.05 vs. obese group.